A compound plant composition for relieving physical fatigue and its preparation process

By combining specific weight parts of plant extracts and using a preparation process involving low-temperature ultrasonic extraction, dual-stage high-pressure homogenization, vacuum degassing, and ultra-high temperature instantaneous sterilization, the problems of existing products such as easy heatiness due to single qi replenishment and significant loss of active ingredients are solved. This provides a highly efficient and stable compound plant composition for relieving physical fatigue, suitable for industrial production.

CN123100824APending Publication Date: 2026-11-17ZHONGNONG DINGSHENG TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611559089.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-09
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing medicinal and food products for relieving physical fatigue have problems such as being prone to causing internal heat when they only replenish qi, not being able to consolidate essence when they only warm yang, having a large loss of active ingredients due to high-temperature processing, and having a low absorption rate. There is a lack of compositions and preparation processes suitable for industrial production.

Method used

The extracts of six raw materials—ginseng, desert cistanche, polygonatum, astragalus, wolfberry, eucommia leaf, cornus officinalis, raspberry, and mulberry—are compounded in specific weight proportions and combined with a preparation process of low-temperature ultrasonic extraction, dual-stage high-pressure homogenization, vacuum degassing, and ultra-high temperature instantaneous sterilization to produce oral liquids, solid beverages, or compressed candies.

Benefits of technology

It achieves high retention rate and synergistic effect of active ingredients, good product stability, is suitable for long-term use, is suitable for industrial production, and each dosage form has good palatability and microbiological indicators that meet food safety standards.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123100824A_ABST
    Figure CN123100824A_ABST
Patent Text Reader

Abstract

This invention discloses a compound plant composition for relieving physical fatigue and its preparation process, belonging to the field of functional food technology that combines medicine and food. Addressing the problems of existing anti-fatigue formulas that are prone to causing internal heat due to simple qi-tonifying methods, lack of essence-strengthening properties due to simple yang-warming methods, and significant loss of active ingredients during high-temperature processing, this invention's composition consists of ginseng extract, desert cistanche extract, polygonatum extract, astragalus extract, wolfberry extract, eucommia leaf extract, cornus extract, raspberry extract, and mulberry extract in specific weight parts. The preparation method includes low-temperature ultrasonic extraction, concentrating and combining, compounding, two-stage high-pressure homogenization, vacuum degassing, ultra-high temperature instantaneous sterilization, and aseptic filling. This invention achieves synergistic effects of tonifying qi, warming yang, nourishing yin, and strengthening essence through a combination of these properties, and employs a low-temperature process to retain active ingredients, improving absorption and utilization. The product can be formulated into oral liquids, solid beverages, compressed candies, or granules, suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of functional food technology that combines medicine and food, specifically to a compound plant composition for relieving physical fatigue and its preparation process. Background Technology

[0002] Modern sub-healthy individuals commonly experience non-disease states such as physical exhaustion, mental fatigue, lower back and knee pain, and decreased energy. There is a sustained market demand for safe and effective food-based products that alleviate physical fatigue. Existing tonic and anti-fatigue formulas have the following shortcomings: First, they tend to focus solely on replenishing Qi, resulting in excessive heat and dryness, which can easily lead to discomfort such as dry mouth and internal heat with long-term use. Second, they tend to focus solely on warming Yang and tonifying the kidneys, lacking the combination of Yin-nourishing and astringent properties, resulting in ineffective replenishment and rapid loss of efficacy. Third, traditional high-temperature boiling or long-term concentration processes easily lead to the decomposition of heat-sensitive active ingredients such as ginsenosides and polygonatum polysaccharides, resulting in low product absorption and slow onset of action. Furthermore, existing publicly available technologies lack synergistic compositions that combine extracts from nine specific raw materials in precise weight proportions while simultaneously addressing Qi replenishment, warming Yang, Yin nourishment, and astringency. Therefore, it is necessary to provide a more balanced compound plant composition with higher retention of active ingredients, suitable for industrial production, and its preparation process. Summary of the Invention

[0003] The technical problem to be solved by this invention is to overcome the shortcomings of existing formulas for relieving physical fatigue, such as easy heatiness due to simple qi replenishment, insufficient essence due to simple yang warming, large loss of active ingredients due to high temperature process, and low absorption rate. The invention provides a compound plant composition with synergistic formulation, high retention rate of active ingredients, and suitable for long-term use, as well as its preparation process.

[0004] To solve the above-mentioned technical problems, the first aspect of the present invention provides a compound plant composition for relieving physical fatigue, which comprises the following raw material extracts in parts by weight: 12-16 parts of ginseng extract, 16-20 parts of desert cistanche extract, 14-18 parts of polygonatum extract, 11-14 parts of astragalus extract, 12-15 parts of wolfberry extract, 9-12 parts of eucommia leaf extract, 8-11 parts of cornus extract, 7-10 parts of raspberry extract, and 6-9 parts of mulberry extract.

[0005] Furthermore, the ginseng extract contains no less than 20% total ginsenosides, the desert cistanche extract contains no less than 25% phenylethanoid glycosides, the polygonatum extract contains no less than 30% polysaccharides, and the astragalus extract contains no less than 0.3% astragaloside A.

[0006] Furthermore, the raw material extract is composed of the following parts by weight: 14 parts ginseng extract, 18 parts desert cistanche extract, 16 parts polygonatum extract, 13 parts astragalus extract, 14 parts wolfberry extract, 10 parts eucommia leaf extract, 9 parts cornus extract, 8 parts raspberry extract, and 7 parts mulberry extract.

[0007] Furthermore, the ginseng extract is a ginseng extract from ginseng that has been artificially cultivated for no more than five years.

[0008] Furthermore, the dosage form of the composition is an oral liquid, a solid beverage, a compressed candy, or granules.

[0009] The second aspect of this invention provides a method for preparing the above-mentioned compound plant composition, comprising the following steps: adding each raw material extract separately to purified water for low-temperature ultrasonic extraction, with an ultrasonic temperature of 55-62℃, an ultrasonic frequency of 20kHz, an extraction time of 35-45min, and a material-to-liquid ratio of 1:15-1:18; filtering and centrifuging to obtain a clear extract; combining the clear extracts according to the stated weight proportions, concentrating, and stirring at 55℃ for 20min for compounding; employing two-stage high-pressure homogenization, with a first-stage pressure of 22-26MPa, a second-stage pressure of 6-9MPa, and a homogenization temperature of 40-48℃, homogenizing twice; degassing under a vacuum of -0.085MPa for 7min; performing ultra-high temperature instantaneous sterilization at 108℃ for 6-8 seconds followed by rapid cooling; and aseptic filling.

[0010] Furthermore, the low-temperature ultrasonic extraction temperature is 58℃, the ultrasonic frequency is 20kHz, the extraction time is 40min, the material-liquid ratio is 1:15-1:18, and the extract is centrifuged at 4000r / min after being filtered through a 200-mesh filter.

[0011] Furthermore, the first-stage pressure of the two-stage high-pressure homogenization is 24 MPa, the second-stage pressure is 7 MPa, the homogenization temperature is 45°C, and the homogenization is performed twice.

[0012] Furthermore, the vacuum degree of the vacuum degassing is -0.085MPa, and the degassing time is 7min; the temperature of the ultra-high temperature instantaneous sterilization is 108℃, and the sterilization time is 7 seconds.

[0013] Furthermore, prior to low-temperature ultrasonic extraction, the raw material extract is screened and tested to ensure that pesticide residues, heavy metals, and microbial indicators meet food or drug safety standards, and that the raw material extract is free of sulfur treatment.

[0014] The advantages of this invention compared to existing technologies are: (1) The present invention uses ginseng, desert cistanche, polygonatum, astragalus, wolfberry, eucommia leaf, cornus, raspberry and mulberry extracts in specific weight parts to form a formula structure that synergistically replenishes qi, warms yang, nourishes yin and consolidates, avoiding the defects of single qi replenishment being too hot and dry and single yang warming damaging yin and replenishing without consolidating.

[0015] (2) Limiting the content of active ingredients such as total ginsenosides, phenylethanoid glycosides, polygonatum polysaccharides, and astragaloside A helps to ensure the stability and effectiveness of the composition.

[0016] (3) The process of combining low-temperature ultrasonic extraction with two-stage high-pressure homogenization can reduce the damage of heat-sensitive active ingredients and make the material system more uniform and refined, which is conducive to improving the absorption and utilization rate.

[0017] (4) The combination of vacuum degassing and ultra-high temperature instantaneous sterilization can extend the shelf life of the product at room temperature while retaining the active ingredients.

[0018] (5) The composition of the present invention can be made into oral liquid, solid beverage, compressed candy or granules, which are suitable for large-scale industrial production.

[0019] Additional aspects and advantages of this application will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of this application. Attached Figure Description

[0020] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0021] Figure 1 This is a control connection diagram in one embodiment of the present invention; Figure 2 This is a flowchart illustrating the workflow of one embodiment of the present invention; Figure 3 This is a diagram showing the composition of a formulation in one embodiment of the present invention. Detailed Implementation

[0022] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0023] Example 1 like Figures 1 to 3 As shown, this embodiment provides a compound herbal composition for relieving physical fatigue, consisting of the following raw material extracts in parts by weight: 14 parts ginseng extract, 18 parts desert cistanche extract, 16 parts polygonatum extract, 13 parts astragalus extract, 14 parts wolfberry extract, 10 parts eucommia leaf extract, 9 parts cornus extract, 8 parts raspberry extract, and 7 parts mulberry extract. The ginseng extract is from ginseng cultivated for no more than five years; the total ginsenoside content in the ginseng extract is not less than 20%, the phenylethanoid glycoside content in the desert cistanche extract is not less than 25%, the polysaccharide content in the polygonatum extract is not less than 30%, and the astragaloside A content in the astragalus extract is not less than 0.3%.

[0024] The preparation method of the composition in this embodiment is as follows: (1) Raw material screening and pretreatment: Each raw material extract is tested to ensure that pesticide residues, heavy metals and microbial indicators meet food or drug safety standards, the content of active ingredients meets the above requirements, and the raw material extracts are free from sulfur treatment and illegal additions.

[0025] (2) Low-temperature ultrasonic fractional extraction: Each raw material extract was added to purified water at a material-to-liquid ratio of 1:15-1:18 and extracted at a constant temperature of 58℃ and ultrasonic conditions of 20kHz for 40 min. The extract was filtered through a 200-mesh filter and centrifuged at 4000 r / min. The clear extracts were collected separately. Extracting each raw material extract separately helps to avoid the decomposition of heat-sensitive active ingredients in different raw materials under prolonged high temperature.

[0026] (3) Combining and concentrating the filtrates: Combine the clarified extracts according to the above weight parts, concentrate under reduced pressure to remove some water, and obtain the concentrated solution.

[0027] (4) Slightly soluble compounding of active ingredients: Stir the concentrated liquid at low speed for 20 minutes under constant temperature of 55℃ to fully dissolve and blend the active substances.

[0028] (5) Two-stage high-pressure homogenization: A two-stage high-pressure homogenizer is used, with a first-stage pressure of 24MPa and a second-stage pressure of 7MPa. The homogenization temperature is 45℃. The homogenization is carried out twice to make the material system uniform and refined.

[0029] (6) Vacuum degassing: Degas for 7 minutes under a vacuum of -0.085MPa to reduce dissolved oxygen in the material and prevent oxidation and deterioration.

[0030] (7) Ultra-high temperature instantaneous sterilization: Ultra-high temperature instantaneous sterilization at 108℃ for 7 seconds is adopted, followed by rapid cooling after sterilization.

[0031] (8) Aseptic filling: Filling is carried out under aseptic conditions to obtain the oral liquid product.

[0032] The resulting product was tested and found to be homogeneous and free of sediment. It showed no obvious stratification after being left at room temperature for 12 months, and its microbiological indicators met national food safety standards.

[0033] Example 2 This embodiment is basically the same as Example 1, except that the weight parts of the raw material extracts are: 12 parts ginseng extract, 20 parts desert cistanche extract, 14 parts polygonatum extract, 14 parts astragalus extract, 12 parts wolfberry extract, 12 parts eucommia leaf extract, 8 parts cornus extract, 10 parts raspberry extract, and 6 parts mulberry extract. The content of active ingredients in each raw material extract meets the aforementioned limits, and the ginseng extract is from ginseng that has been artificially cultivated for no more than five years. The preparation method is the same as in Example 1. The obtained composition is mixed with conventional excipients acceptable for food to prepare a solid beverage. This embodiment illustrates that by adjusting the proportions of each raw material within the stated weight range, a homogeneous composition can still be obtained.

[0034] Example 3 This embodiment is basically the same as Example 1, except that the weight parts of the raw material extracts are: 16 parts ginseng extract, 16 parts desert cistanche extract, 18 parts polygonatum extract, 11 parts astragalus extract, 15 parts wolfberry extract, 9 parts eucommia leaf extract, 11 parts cornus extract, 7 parts raspberry extract, and 9 parts mulberry extract. The content of active ingredients in each raw material extract meets the stated limits. The preparation method is the same as in Example 1. The obtained composition is mixed with conventional food-acceptable excipients to make compressed candies or granules. This embodiment illustrates that adjusting the proportions of each raw material within the stated weight range can produce different dosage forms.

[0035] Example 4 This embodiment is basically the same as Embodiment 1, except that the preparation process parameters are adjusted within the specified range: the low-temperature ultrasonic extraction temperature is 55℃, the ultrasonic frequency is 20kHz, the extraction time is 45min, and the material-to-liquid ratio is 1:18; after filtration and centrifugation, the clarified extracts are combined, concentrated under reduced pressure, and then reconstituted by low-speed stirring at 55℃ for 20min; the first stage of the two-stage high-pressure homogenization is at a pressure of 22MPa, the second stage at a pressure of 9MPa, and the homogenization temperature is 48℃, with homogenization performed twice; degassing is carried out under a vacuum of -0.085MPa for 7min; ultra-high temperature instantaneous sterilization is performed at 108℃ for 8 seconds followed by rapid cooling; aseptic filling yields the finished granule product. The preparation process parameters described in this embodiment are all feasible.

[0036] Experimental Example 1: Determination of Retention Rate of Active Ingredients Test subjects: the compositions obtained in Examples 1 to 4, and Comparative Examples 1 to 4.

[0037] Scale settings: Comparative Example 1: The formulation is the same as in Example 1, but the low-temperature ultrasonic extraction is replaced by water extraction at 100°C for 60 min, and the remaining steps are the same as in Example 1; Comparative Example 2: The formulation is the same as in Example 1, but the two-stage high-pressure homogenization step is omitted, and the remaining steps are the same as in Example 1; Comparative Example 3: The formulation is the same as in Example 1, but the vacuum degassing step is omitted, and the remaining steps are the same as in Example 1; Comparative Example 4: The formula is the same as in Example 1, but pasteurization at 85°C for 30 minutes is used instead of ultra-high temperature instantaneous sterilization at 108°C for 6-8 seconds. The remaining steps are the same as in Example 1.

[0038] The above comparative examples are only used to verify the process effect of the present invention and do not constitute a limitation on the scope of protection of the present invention.

[0039] Detection method: Total ginsenosides were determined by high performance liquid chromatography (HPLC) using a C18 column with acetonitrile-water gradient elution and a detection wavelength of 203 nm, and were expressed as total ginsenosides Rg1, Re, and Rb1. Phenylene glycol glycosides were determined by HPLC using methanol-water (30:70) as the mobile phase and a detection wavelength of 330 nm, and were expressed as verbascosides. Polygonatum polysaccharides were determined by the phenol-sulfuric acid method and a detection wavelength of 490 nm. Astragaloside A was determined by HPLC-ELSD.

[0040] Retention rate (%) = active ingredient content in the final product / theoretical content of raw materials × 100%.

[0041] Table 1. Results of active ingredient retention rates in each example and comparative example. ; Results Analysis: Table 1 shows that after using a synergistic process of low-temperature ultrasonic extraction, two-stage high-pressure homogenization, vacuum degassing, and ultra-high temperature instantaneous sterilization in Examples 1 to 4, the retention rates of total ginsenosides, phenylethanoid glycosides, Polygonatum polysaccharides, and astragaloside A were significantly higher than those in Comparative Examples 1 to 4. In Examples 1 to 3, the retention rates of each active ingredient reached over 89%. Comparative Example 1 used high-temperature water extraction, resulting in significant loss of heat-sensitive components; Comparative Example 2 omitted two-stage high-pressure homogenization, leading to decreased system homogeneity; Comparative Example 3 omitted vacuum degassing, resulting in increased oxidation losses; and Comparative Example 4 used pasteurization, resulting in a decreased retention rate of active ingredients. This indicates that the process conditions described in this invention are beneficial for retaining active ingredients.

[0042] Experimental Example 2: System Stability Test Test subjects: the oral liquids obtained in Examples 1 to 4.

[0043] Experimental method: Each sample was placed at room temperature for 12 months. Samples were taken at 0, 3, 6 and 12 months to observe the stratification and precipitation, measure the centrifugation sedimentation rate, and detect the total number of colonies, coliforms and molds and yeasts.

[0044] Centrifugal sedimentation rate (%) = (dry weight of sediment after centrifugation at 4000 r / min for 30 min) / total solids × 100%.

[0045] Table 2. Results of room temperature stability of oral solutions in each example. ; Results analysis: Table 2 shows that the oral liquids obtained in Examples 1 to 4 did not show obvious stratification after being stored at room temperature for 12 months, and the centrifugation sedimentation rate was less than 0.50%. The microbial indicators met the national food safety standards, indicating that the composition system of the present invention is stable and suitable for room temperature storage.

[0046] Experiment Example 3: Functional Test for Relieving Physical Fatigue Test subjects: the compositions obtained in Examples 1 to 4, and Comparative Examples 1 to 4.

[0047] Experimental animals: SPF-grade male Kunming mice, weighing 25-35g, were randomly divided into 10 groups of 20 mice each after 7 days of acclimatization. The blank control group was administered an equal volume of physiological saline by gavage; the example groups and comparative groups were administered the corresponding samples by gavage at a dose of 0.5 mL / 10g body weight for 30 consecutive days. During the experiment, mice had free access to water and food.

[0048] Test method: Weighted swimming test: One hour after gavage on day 30, mice were placed in water at 25±1℃ with a tail bearing 6% of their body weight. The time taken to swim to exhaustion was recorded, with the standard being that the mouse could not surface for respiration for 8 seconds after sinking to the bottom. Blood was collected immediately after swimming. Blood lactate was measured using a portable blood lactate analyzer; liver glycogen was measured using the anthrone method; and serum urea nitrogen was measured using the urease method.

[0049] Table 3. Results of weight-bearing swimming time and biochemical indicators for mice in each example and comparative example (n=20, x±s) ; Note: Compared with the blank control group, *P<0.05, **P<0.01.

[0050] Results Analysis: Table 3 shows that the swimming time of mice in each example group under load was significantly longer than that in the blank control group. After exercise, the blood lactate level and serum urea nitrogen level were significantly lower than those in the blank control group, while the liver glycogen content was significantly higher, indicating that the composition of the present invention has the effect of relieving physical fatigue. Among them, Examples 1 to 4 showed better results than Comparative Examples 1 to 4, indicating that the process conditions such as low-temperature ultrasonic extraction, two-stage high-pressure homogenization, vacuum degassing, and ultra-high temperature instantaneous sterilization are beneficial for preserving active ingredients, thereby improving the anti-fatigue effect.

[0051] Experiment Example 4: Sensory Evaluation Experiment Test subjects: oral liquid obtained in Example 1, solid beverage obtained in Example 2, compressed candy obtained in Example 3, and granules obtained in Example 4.

[0052] Evaluation Method: Twenty trained sensory evaluators, half male and half female, aged 22-35, were selected. Samples were randomly numbered and provided in random order. Evaluators did not consume foods with pungent tastes before evaluation and rinsed their mouths with purified water after each evaluation. A 0-10 scoring system was used, with higher scores indicating higher acceptability. Taste, mouthfeel, texture, and overall acceptability were evaluated.

[0053] Table 4 Sensory evaluation results for each dosage form (n=20, x±s) ; Results Analysis: Table 4 shows that the composition of the present invention can be made into oral liquid, solid beverage, compressed candy or granules. The taste, mouthfeel, texture and overall acceptability of each dosage form are good, indicating that the present invention has good product palatability while retaining the active ingredients.

[0054] Experimental Example 5: Quality Index Tests of Different Dosage Forms Test subjects: Example 1 oral liquid, Example 2 solid beverage, Example 3 compressed candy, Example 4 granules.

[0055] Testing items: appearance, moisture or solubility, disintegration time, total retention of active ingredients, microbial indicators, and stability at room temperature for 12 months.

[0056] Table 5. Results of quality indicators for different dosage forms ; Results Analysis: Table 5 shows that the composition of the present invention can be made into oral liquid, solid beverage, compressed candy or granules. Each dosage form has good appearance, solubility or disintegration, high retention rate of active ingredients, and microbial indicators meet food safety standards, making it suitable for industrial production.

[0057] Experimental Example 6: Accelerated Stability Test Test subject: The oral liquid obtained in Example 1.

[0058] Test conditions: 40℃±2℃, relative humidity 75%±5%. Samples were taken at 0, 1, 2, 3 and 6 months to test the retention rate of active ingredients, total number of colonies and stratification.

[0059] Table 6 Results of Accelerated Stability Test of Oral Liquid in Example 1 ; Results Analysis: Table 6 shows that after 6 months of accelerated testing, the retention rates of total ginsenosides, phenylethanoid glycosides, Polygonatum polysaccharides, and astragaloside A in the oral liquid of Example 1 still reached 93.6%, 92.9%, 94.0%, and 92.5%, respectively, with no stratification. The microbiological indicators met national food safety standards. This indicates that the present invention, through the combination of vacuum degassing and ultra-high temperature instantaneous sterilization, can extend the shelf life of the product at room temperature while retaining the active ingredients.

[0060] Obviously, the above-described embodiments are only used to illustrate the technical solutions of the present invention, and not to limit them. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some or all of the technical features therein; and these modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention also intends to include these modifications and variations.

Claims

1. A compound herbal composition for relieving physical fatigue, characterized in that, It contains the following raw material extracts in parts by weight: ginseng extract 12-16 parts, desert cistanche extract 16-20 parts, polygonatum extract 14-18 parts, astragalus extract 11-14 parts, wolfberry extract 12-15 parts, eucommia leaf extract 9-12 parts, cornus extract 8-11 parts, raspberry extract 7-10 parts, and mulberry extract 6-9 parts.

2. The compound plant composition for relieving physical fatigue according to claim 1, characterized in that, The ginseng extract contains no less than 20% total ginsenosides, the desert cistanche extract contains no less than 25% phenylethanoid glycosides, the polygonatum extract contains no less than 30% polysaccharides, and the astragalus extract contains no less than 0.3% astragaloside A.

3. The compound plant composition for relieving physical fatigue according to claim 1, characterized in that, The raw material extract consists of the following parts by weight: 14 parts ginseng extract, 18 parts desert cistanche extract, 16 parts polygonatum extract, 13 parts astragalus extract, 14 parts wolfberry extract, 10 parts eucommia leaf extract, 9 parts cornus extract, 8 parts raspberry extract, and 7 parts mulberry extract.

4. The compound plant composition for relieving physical fatigue according to claim 1, characterized in that, The ginseng extract is from ginseng that has been artificially cultivated for no more than five years.

5. The compound plant composition for relieving physical fatigue according to claim 1, characterized in that, The dosage form of the composition is an oral liquid, a solid beverage, a compressed candy, or granules.

6. A method for preparing the compound plant composition according to any one of claims 1 to 5, characterized in that, The process includes the following steps: Extracting each raw material extract separately into purified water for low-temperature ultrasonic extraction at a temperature of 55-62℃, a frequency of 20kHz, an extraction time of 35-45 minutes, and a material-to-liquid ratio of 1:15-1:18; filtering and centrifuging to obtain a clear extract; combining the clear extracts according to the weight proportions of any one of claims 1 to 5, concentrating, and then stirring at 55℃ for 20 minutes for compounding; employing two-stage high-pressure homogenization, with a first-stage pressure of 22-26MPa and a second-stage pressure of 6-9MPa, and a homogenization temperature of 40-48℃, homogenizing twice; degassing under a vacuum of -0.085MPa for 7 minutes; performing ultra-high temperature instantaneous sterilization at 108℃ for 6-8 seconds followed by rapid cooling; and aseptic filling.

7. The preparation method according to claim 6, characterized in that, The low-temperature ultrasonic extraction was performed at a temperature of 58°C, an ultrasonic frequency of 20kHz, an extraction time of 40min, and a material-to-liquid ratio of 1:15-1:

18. The extract was filtered through a 200-mesh filter and then centrifuged at 4000r / min.

8. The preparation method according to claim 6, characterized in that, The two-stage high-pressure homogenizer has a first-stage pressure of 24 MPa, a second-stage pressure of 7 MPa, a homogenization temperature of 45°C, and undergoes homogenization twice.

9. The preparation method according to claim 6, characterized in that, The vacuum degree of the vacuum degassing is -0.085MPa, and the degassing time is 7min; the temperature of the ultra-high temperature instantaneous sterilization is 108℃, and the sterilization time is 7 seconds.

10. The preparation method according to claim 6, characterized in that, Prior to low-temperature ultrasonic extraction, the raw material extract is screened and tested to ensure that pesticide residues, heavy metals, and microbial indicators meet food or drug safety standards, and that the raw material extract is free of sulfur treatment.